For: | Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 [PMID: 37213403 DOI: 10.3748/wjg.v29.i17.2666] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i17/2666.htm |
Number | Citing Articles |
1 |
Lukas Bethlehem, Maria Manuela Estevinho, Ari Grinspan, Fernando Magro, Jeremiah J Faith, Jean-Frederic Colombel. Microbiota therapeutics for inflammatory bowel disease: the way forward. The Lancet Gastroenterology & Hepatology 2024; 9(5): 476 doi: 10.1016/S2468-1253(23)00441-7
|
2 |
Junyi Bai, Ying Wang, Fuhao Li, Yueyao Wu, Jun Chen, Meng Li, Xi Wang, Bin Lv. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review. Science Progress 2024; 107(2) doi: 10.1177/00368504241253709
|
3 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2024; : gutjnl-2023-331550 doi: 10.1136/gutjnl-2023-331550
|
4 |
Xueyi Qian, Hua Jiang, Yao Wu, Huimin Shao, Weijie He, Yinmei He, Xin Bao, Lianjun He, Yuliang Jia, Zhenyu Xu. Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice. Future Microbiology 2023; 18(17): 1251 doi: 10.2217/fmb-2023-0001
|
5 |
Jonathan A. Montrose, Satya Kurada, Monika Fischer. Current and future microbiome-based therapies in inflammatory bowel disease. Current Opinion in Gastroenterology 2024; 40(4): 258 doi: 10.1097/MOG.0000000000001027
|
6 |
Umang Arora, Saurabh Kedia, Vineet Ahuja. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research 2024; 22(1): 44 doi: 10.5217/ir.2023.00085
|
7 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; 148: 189 doi: 10.1016/j.jhin.2024.03.001
|
8 |
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt. The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.60786
|